AAAAAA

   
Results: 1-12 |
Results: 12
Strategies for pro-active case-finding in leprosy control - Discussion
Authors: Gupte, MD Klatser, PR Gillis, TP Dockrell, HM Grosset, JH Noordeen, SK
Citation: Md. Gupte et al., Strategies for pro-active case-finding in leprosy control - Discussion, LEPROSY REV, 71, 2000, pp. S32-S32
South India immunoprophylaxis trial against leprosy: relevance of the findings in the context of trends in leprosy
Authors: Gupte, MD
Citation: Md. Gupte, South India immunoprophylaxis trial against leprosy: relevance of the findings in the context of trends in leprosy, LEPROSY REV, 71, 2000, pp. S43-S47
South India immunoprophylaxis trial against leprosy: relevance of the findings in the context of trends in leprosy - Discussion
Authors: Colston, MJ Gupte, MD Noordeen, SK Smith, C Britton, W Klatser, PR Grosset, JH
Citation: Mj. Colston et al., South India immunoprophylaxis trial against leprosy: relevance of the findings in the context of trends in leprosy - Discussion, LEPROSY REV, 71, 2000, pp. S47-S49
Use of a Mycobacterium leprae dipstick to classify patients with leprosy -Discussion
Authors: Britton, W Klatser, PR Noordeen, SK Gupte, MD Grosset, JH Nath, I Kaplan, G van Brakel, WH Ji, BH Brennan, PJ Sengupta, U Sow, SO Gillis, TP Smith, C Ottenhoff, THM Dockrell, HM Modlin, RL
Citation: W. Britton et al., Use of a Mycobacterium leprae dipstick to classify patients with leprosy -Discussion, LEPROSY REV, 71, 2000, pp. S69-S72
Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy
Authors: Gupte, MD
Citation: Md. Gupte, Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy, LEPROSY REV, 71, 2000, pp. S77-S80
Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy - Discussion
Authors: Noordeen, SK Gupte, MD Sow, SO
Citation: Sk. Noordeen et al., Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy - Discussion, LEPROSY REV, 71, 2000, pp. S80-S80
Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy - Discussion
Authors: Gupte, MD Ji, BH Lockwood, DNJ Grosset, JH Van Brakel, WH
Citation: Md. Gupte et al., Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy - Discussion, LEPROSY REV, 71, 2000, pp. S87-S87
Pathogenesis of nerve damage in leprosy: genetic polymorphism regulates the production of TNF alpha - Discussion
Authors: Smith, C Brennan, PJ Lockwood, DNJ Britton, W Gupte, MD van Brakel, WH Ji, BH Nunn, P Rambukkana, A Cole, S Nath, I
Citation: C. Smith et al., Pathogenesis of nerve damage in leprosy: genetic polymorphism regulates the production of TNF alpha - Discussion, LEPROSY REV, 71, 2000, pp. S158-S160
Research component in the global alliance - Discussion
Authors: Gupte, MD Ji, BH Van Brakel, WH Smith, C Britton, W
Citation: Md. Gupte et al., Research component in the global alliance - Discussion, LEPROSY REV, 71, 2000, pp. S189-S189
Comparative leprosy vaccine trial in South India (Reprinted from Indian Journal of Leprosy, vol 70, 1998)
Authors: Gupte, MD
Citation: Md. Gupte, Comparative leprosy vaccine trial in South India (Reprinted from Indian Journal of Leprosy, vol 70, 1998), LEPROSY REV, 70(1), 1999, pp. 123-123
SIMLEP: a simulation model for leprosy transmission and control
Authors: Meima, A Gupte, MD van Oortmarssen, GJ Habbema, JDF
Citation: A. Meima et al., SIMLEP: a simulation model for leprosy transmission and control, INT J LEPR, 67(3), 1999, pp. 215-236
Lot quality assurance sampling (LQAS) for monitoring a leprosy eliminationprogram
Authors: Gupte, MD Narasimhamurthy, B
Citation: Md. Gupte et B. Narasimhamurthy, Lot quality assurance sampling (LQAS) for monitoring a leprosy eliminationprogram, INT J LEPR, 67(2), 1999, pp. 143-149
Risultati: 1-12 |